PHK
AVXL icon

Point72 Hong Kong’s Anavex Life Sciences AVXL Stock Holding History

Point72 Hong Kong’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-771
Closed -$8K – 199
2022
Q3 		$8K Buy
+771
New +$8.14K ﹤0.01% 1742
2022
Q2 		– Sell
-4,063
Closed -$50K – 1905
2022
Q1 		$50K Sell
4,063
-4,946
-55% -$60.8K ﹤0.01% 1331
2021
Q4 		$156K Buy
9,009
+5,428
+152% +$103K 0.01% 1074
2021
Q3 		$64K Buy
+3,581
New +$71.3K ﹤0.01% 1461
2021
Q2 		– Sell
-1,350
Closed -$20K – 1912
2021
Q1 		$20K Buy
+1,350
New +$14.7K ﹤0.01% 1471

Other funds holding AVXL

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Point72 Hong Kong's AVXL Position: Q4 2022 in Review

Point72 Hong Kong sold out of Anavex Life Sciences (AVXL) in Q4 2022, closing a stake of 771 shares — an estimated $8K sold.

Point72 Hong Kong first reported a position in AVXL in Q1 2021 and held it in 5 quarters. The position peaked at $156K in Q4 2021. 139 funds tracked by Wall St. Rank hold AVXL as of Q4 2022.

  • Point72 Hong Kong reported no remaining Anavex Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 771 Anavex Life Sciences shares in Q4 2022, an estimated $8K.
  • Point72 Hong Kong first reported a position in Anavex Life Sciences in Q1 2021 and held it in 5 quarters.
  • Point72 Hong Kong's Anavex Life Sciences position peaked at $156K in Q4 2021.
  • 139 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.